Adjunctive Valproic Acid in Management-Refractory Hyperactive Delirium: A Case Series and Rationale

J Neuropsychiatry Clin Neurosci. 2015 Fall;27(4):365-70. doi: 10.1176/appi.neuropsych.14080190. Epub 2015 Mar 24.

Abstract

Patients with delirium may fail to respond to standard therapies. Sixteen patients with management-refractory hyperactive delirium responded to adjunctive valproic acid, with complete resolution of hyperactive delirium in 13 cases. A rationale for using valproic acid in such circumstances is discussed.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antimanic Agents / therapeutic use*
  • Antipsychotic Agents / therapeutic use*
  • Benzodiazepines / therapeutic use*
  • Delirium / drug therapy*
  • Drug Therapy, Combination
  • Female
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • Treatment Outcome
  • Valproic Acid / therapeutic use*

Substances

  • Antimanic Agents
  • Antipsychotic Agents
  • Benzodiazepines
  • Valproic Acid